BRCA1 rs943068318: Understanding This Rare Genetic Variant
The rs943068318 variant is a rare genetic alteration located within the BRCA1 gene, which plays a vital role in DNA repair processes. It is currently studied for its potential associations with hereditary breast and ovarian cancer syndromes.
What each genotype means
Typical BRCA1 genetic profile
This genotype represents the most common sequence found in the general population at this specific location in the BRCA1 gene. It is considered the baseline or reference state, and there is no evidence suggesting this specific configuration contributes to hereditary cancer risk.
This is the predominant genotype observed across all global populations.
Rare BRCA1 genetic variant
You carry one copy of a rare genetic alteration in the BRCA1 gene. Because this variant is extremely uncommon, current scientific evidence is limited regarding its specific impact on DNA repair or cancer susceptibility, and it should not be interpreted as a definitive indicator of health risk.
This genotype is very rare, occurring in approximately 0.00003843 of the population based on current genomic databases.
Rare BRCA1 genetic variant
You carry two copies of a rare genetic alteration in the BRCA1 gene. Due to the rarity of this variant, there is limited clinical data available to determine if this specific genotype influences BRCA1 function or hereditary cancer risk, and it is not currently classified as a known pathogenic mutation.
This homozygous genotype is exceptionally rare and is observed in a negligible fraction of the global population.
What is rs943068318 and Where is it Located?
The identifier rs943068318 refers to a specific single nucleotide polymorphism (SNP) found within the BRCA1 gene. In genomics, an rsID (reference SNP cluster ID) is a unique label assigned by researchers to track a specific location in the human genome. This variant sits on chromosome 17, which houses the BRCA1 gene. Because the human genome is vast, scientists use these identifiers to pinpoint exact locations where a single DNA building block—a nucleotide—differs between individuals. While many variants are common, rs943068318 is classified as rare, meaning it is found in only a very small fraction of the global population. Understanding its location helps researchers determine if the change occurs in a region of the gene that is critical for protein production or if it resides in a non-coding region that might influence how the gene is regulated.
The Role of the BRCA1 Gene
The BRCA1 gene, or Breast Cancer 1, provides instructions for making a protein that acts as a tumor suppressor. This protein is essential for maintaining genomic stability by repairing damaged DNA. When DNA strands break, the BRCA1 protein helps coordinate the repair process, ensuring that genetic information is copied accurately during cell division. If the BRCA1 gene is altered, the resulting protein may not function correctly, which can lead to the accumulation of genetic errors within cells. Over time, these errors can disrupt normal cell growth and increase the risk of developing certain types of cancer, particularly breast and ovarian cancers. Because of its central role in DNA repair, variants in this gene are a major focus of clinical research aimed at understanding hereditary cancer syndromes and improving early detection strategies for high-risk families.
Research Associations and Evidence Strength
Current evidence regarding the clinical impact of rs943068318 is considered limited. In the field of genomics, 'limited' evidence means that while the variant has been identified and cataloged, there is not yet enough robust, peer-reviewed data to definitively classify it as a primary driver of disease or to quantify its exact risk contribution. Research into BRCA1 variants often involves large-scale studies of families with histories of hereditary breast and ovarian cancer. Scientists compare the presence of specific variants against clinical outcomes to see if a pattern emerges. Because rs943068318 is rare, gathering sufficient data to reach a statistical consensus is challenging. It is important to note that the presence of a variant in a cancer-associated gene does not automatically mean an individual will develop cancer. Many factors, including other genetic modifiers and environmental influences, contribute to overall health outcomes.
Population Frequency
The rs943068318 variant is extremely rare, with a reported population frequency of approximately 0.00003843. This low frequency indicates that the variant is not widely distributed across the general population. In genetic studies, frequency data is gathered from large databases like gnomAD, which aggregate genomic information from diverse groups of people. Because this variant is so uncommon, it is difficult to determine if it is more prevalent in specific ancestral groups or if it appears sporadically across different populations. Rare variants often require specialized sequencing techniques to detect, and their scarcity makes it difficult for researchers to perform the large-scale association studies needed to confirm their biological significance. As more individuals participate in genomic research, our understanding of the distribution and potential impact of such rare variants will continue to evolve.
What You Can and Cannot Do With This Information
If you have received information about this variant, it is essential to understand its limitations. Genetic data is complex, and a single variant rarely tells the whole story of your health. You cannot use this information to diagnose yourself or predict a future health outcome with certainty. If you are concerned about your family history of cancer or your personal genetic profile, the most appropriate step is to consult with a certified genetic counselor or a medical professional. They can help interpret your results in the context of your overall health, family history, and other clinical factors. Avoid making medical decisions based solely on raw genetic data. Always discuss any findings with a clinician who can provide personalized guidance, explain the limitations of current evidence, and recommend appropriate screening or monitoring if necessary.
How common is this variant?
The variant rs943068318 is very rare, with a reported population frequency of 0.00003843. It is observed at very low levels across global populations.
Frequently asked questions
What does it mean if I have a BRCA1 variant?
Having a BRCA1 variant does not automatically mean you will develop cancer. BRCA1 is involved in DNA repair, and while some variants are linked to higher cancer risks, many are benign or have unknown significance; always consult a genetic counselor to understand your specific results.
Is rs943068318 a known cause of cancer?
The evidence for rs943068318 is currently limited, meaning it is not definitively classified as a cause of cancer. More research is needed to understand its specific biological impact and clinical relevance.
Should I get tested for BRCA1 variants?
Genetic testing is typically recommended for individuals with a strong family history of breast or ovarian cancer. You should discuss the benefits and limitations of testing with a healthcare provider or genetic counselor to see if it is appropriate for your situation.
How can I find out if I have this variant?
This variant is typically identified through clinical-grade genetic sequencing ordered by a physician. Direct-to-consumer tests may not always cover rare variants like rs943068318, so clinical testing is the most reliable method.
Sources & further reading
Educational information only, last refreshed 9/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs943068318?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BRCA1
This rare variant has been recently annotated in clinical databases as a potential contributor to hereditary breast and ovarian cancer risk.
Variant identified in polygenic risk scores for breast cancer susceptibility.
A rare variant located in the BRCA1 gene, relevant to reproductive genetic counseling and the assessment of hereditary cancer risk.
A very rare variant identified in recent genomic studies, currently being investigated for potential associations with reproductive phenotypes.
This BRCA1 variant (p.Pro871Leu) is a common polymorphism often evaluated in breast cancer risk studies, though it is generally considered to have no clinical significance for hereditary breast and ovarian cancer syndrome.
A common BRCA1 variant (p.Ser1613Gly) often included in polygenic risk scores for breast cancer, but not classified as a pathogenic mutation for hereditary cancer syndromes.